前收市價 | 14.40 |
開市 | 13.50 |
買盤 | 12.60 |
賣出價 | 16.00 |
拍板 | 40.00 |
到期日 | 2026-01-16 |
今日波幅 | 13.50 - 14.40 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 1.28k |
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.
Biohaven stock tumbled Wednesday after the company's experimental protein-degrading drug lagged investor expectations.